Arab Board Clinical Pathology Part 1 study materials
Arab Board Clinical Pathology Part 1 study resources

A Falling Platelet Count on the Ward: Clot or Consumptive Process?

Arab Board Clinical Pathology Part 1 · Put your knowledge to work in context.

All case studies

A Falling Platelet Count on the Ward: Clot or Consumptive Process?

A 62-year-old woman with a community-acquired pneumonia has been on low-molecular-weight heparin (enoxaparin 40 mg daily) for VTE prophylaxis for 6 days. Her platelet count was 240 × 10⁹/L on admission and is now 78 × 10⁹/L. She has no bleeding. The haematology analyser (impedance plus optical) flags the sample. A citrate tube was also sent. The laboratory scientist notes that the EDTA sample was received 5 hours after collection and that the analyser's platelet histogram shows a rising curve at the far right with a 'platelet clumps' flag. The ward is asking whether this is heparin-induced thrombocytopenia (HIT) and whether to stop the heparin.

1. List the differential diagnoses for the falling platelet count and explain how the sample findings help distinguish them.

Read the worked answer

Differential:

  1. EDTA-induced pseudothrombocytopenia (platelet clumping/ satellitism) - the analyser flag and right-shifted histogram support clumping.
  2. HIT - timing fits (day 6), but HIT typically causes a >50% fall and often thrombosis; it does not cause clumping.
  3. Sepsis-associated thrombocytopenia / DIC - pneumonia is a trigger; check coagulation and fibrinogen.
  4. Drug-induced (non-heparin) thrombocytopenia.
  5. Clot in the EDTA tube - a partial clot consumes platelets and gives a falsely low count; the 5-hour delay increases clot risk.

Interpretation of findings: the 'platelet clumps' flag and right-shifted histogram point to pseudothrombocytopenia, not true thrombocytopenia. A true consumptive process would show a normal histogram shape and no clump flag. The delay to analysis is a separate pre-analytical risk (clotting), which can also lower the count.

Key point: do not diagnose HIT on a clumped EDTA sample.

2. Describe the confirmatory steps you would take before any change to anticoagulation.

Read the worked answer

Stepwise confirmation:

  1. Examine the EDTA blood film - look for platelet clumps and platelet satellitism around neutrophils. Clumps confirm pseudothrombocytopenia.
  2. Repeat in a citrate tube (correcting for dilution) or a heparin tube, and analyse promptly (within 1–2 h). A normal count in citrate/heparin with clumping in EDTA confirms EDTA-dependent pseudothrombocytopenia.
  3. Assess for a true clot - inspect the EDTA tube for fibrin strands; if present, the count is invalid regardless.
  4. Only if true thrombocytopenia is confirmed proceed to HIT assessment: calculate the 4Ts score, check for thrombosis, and if indicated order a PF4/heparin immunoassay (with confirmatory functional assay if available).

Immediate clinical advice: the low count is most likely spurious; do not stop heparin on the basis of a clumped EDTA sample. However, because the patient is on day 6 of heparin, keep HIT on the differential and confirm with a valid sample urgently.

3. What pre-analytical and laboratory-process failures are evident, and how would you correct them?

Read the worked answer

Failures:

  • Delay to analysis (5 h): EDTA samples for platelet counts should be analysed within 4 h; delay promotes clumping and clotting.
  • EDTA-only sampling in a patient with a clump flag: best practice is to repeat in an alternative anticoagulant.
  • No film review before reporting a critical fall: a >50% fall should trigger film review and a call to the clinician.

Corrections:

  • Set a turnaround standard: haematology samples analysed within 2 h of receipt; escalate if delayed.
  • Add an SOP rule: any sample with a platelet clump flag or a >50% fall in platelets must be film-reviewed and, if clumping is seen, repeated in citrate/heparin.
  • Document the alternative anticoagulant on the report.
  • Audit delayed samples monthly and feedback to portering/phlebotomy.
  • Educate clinical staff that a falling count must be confirmed on a valid sample before acting.